Navigation Links
Partnership Uses Video to Bring Complex Science into Focus
Date:7/10/2008

Mains Associates partners with Emmy Award winning TV correspondent Marc Levenson to provide high-quality video content development to Research-based organizations.

Berkeley, CA (PRWEB) July 10, 2008 -- Mains Associates is pleased to announce an agreement with Emmy award winning TV science correspondent Marc Levenson to develop, produce, and host original video content for its Life Science clients.

Mains Associates will work with Levenson to help clients translate complex scientific topics into short, compelling video segments that are tailored to each client's specific audience, and deliver them through the media channels best suited for achieving specific business objectives.

"When communicating science-based information to investors, customers, partners, or collaborators, our clients will now be able to share their message through video at the same high level of quality, professionalism, and clarity that they have come to expect from all content services provided by Mains Associates," says Managing Director Jason Cardillo. "We are excited about working with people of Marc's caliber to provide a larger set of services."

Levenson, co-host of the nationally syndicated science and technology series 'Tech Closeup,' is a winner of three Emmy Awards for his science and technology reporting and writing. Levenson's professional career has spanned more than thirty years, and includes science reporting for CBS, CNN, PBS, and TechTV. In addition to his Emmy Awards, Marc has received a Cine Golden Eagle, and numerous Associated Press Awards.

"Elevating science literacy is a monumental challenge because people fear what they don't understand," says Levenson. "I've focused my career on provid
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results
2. Toys"R"Us, Inc. Announces Partnership With Safe Kids Worldwide to Help Keep Children Safe
3. The Quantum Group Expands Payer Partnerships
4. AEGON and Right To Play Announce Global Partnership
5. MED3OOO and Mitsui & Co. Complete U.S. and Global Healthcare Partnership Agreement
6. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
7. FOX Networks Group in Partnership with Portico Learning Solutions Launches Online Employee Health and Safety Orientation Course for Over 3,300 Employees
8. Neutrogena(R) Partnership For Skin Health Taps Malin Akerman to Educate About Skin Cancer Detection
9. Abbott and Partnership for a Drug-Free America Launch Not In My House to Help Parents Secure Their Homes from Teen Prescription Drug Misuse and Abuse
10. FHS Corp Signs Partnership Agreement With Concuity
11. Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Award-winning author Jam...ull-length book, Short White Coat: Lessons from Pa...path through the third year of medical school--the... PHILADELPHIA, PA (PRWEB) December 2, 2009 -- Mo...ind themselves dressed in a tiny hospital gown or ...
(Date:12/2/2009)..., , CAMPBELL, Calif., Dec. 1 /PRNews...icated radio show, Dr. Rafael Pelayo, Associate Pr...Stanford University School of Medicine, recommende... a healthy sleep plan for people trying to achieve... ,, "Background noise is a problem for people w...
(Date:12/2/2009)..., , CHICAGO, Dec. 2 A rand...vative therapy to a minimally invasive treatment c...herniated disc revealed that while both treatments...ession kept patients pain free up to two years lat...ere presented today at the annual meeting of the R...
(Date:12/2/2009)..., , SEATTLE, Dec. 2 /PRNewswire-Fir...nd MTA: CTIC) announced today that Ruth Pettengell...don, the lead investigator for the PIX 301 EXTEND ...e III trial in relapsed/refractory aggressive non-...g of the American Society of Hematology on Saturda...
(Date:12/2/2009)... CHICAGO Results of a large-scale clinical trial...ological Society of North America (RSNA) provide t...screening ultrasound for women with dense breasts ...ition, the study confirmed that MRI is highly sens...und that annual screening with ultrasound in addit...
Breaking Medicine News(10 mins):Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 3Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 4Health News:Annual screening with breast ultrasound or MRI could benefit some women 2
...randomized study finds large doses of folic acid a...s., - A separate comparison in the same study sup...owering., NEW ORLEANS, Nov. 11 Folic acid is saf... results from the Study of the Effectiveness of Ad...
...an medical,correspondent has received the 2008 Ame...t Award for excellence in medical and science jour...nored for "his enterprising,in-depth reporting tha...htfulness in the fight against heart disease,",acc...
...rth American application,activity for individually...ober year-over-year, according to the MIB Life Ind...ity remained stable off -1.9%, compared to the,sam... -2.3% in October year-over-year, all,ages combine...
...ll-known etiologic factor associated with chronic ...here is a correlation between increased ethanol co...oping chronic pancreatitis (CP). An excessive cons... clinical practice, the coincidence of both diseas...
...e-FirstCall/ - SXC Health Solutions Corp.,("SXC" o...ding provider of,pharmacy benefits management serv...stor event at the Yale Club in New York City on Tu...cutives and customers. SXC executives will offer a...
...Hospital Closures and Bankruptcies, PRINCETON, N....pital Association shows that U.S. hospitals enjoye... Jersey hospitals,experienced an unprecedented ras...verage operating margin of 4.3,percent in 2007. Op...
Other Medicine News:Health News:Study Finds Folic Acid Not Cardioprotective, Though Safe 2Health News:Study Finds Folic Acid Not Cardioprotective, Though Safe 3Health News:MIB Life Index Reports North American Life Insurance Activity Off 1.8% in October 2Health News:Possible association between CP and LC of alcoholic etiology 2Health News:SXC Health Solutions to host analyst and institutional investor event 2Health News:Nation's Hospitals Thrive as N.J. Facilities Struggle 2
(Date:12/1/2009)..., , MINNETONKA, Minn., Dec. 1 /PRNewswire/ ...logy solutions company specializing in clinical st...GHTEN ®, its industry-leading EDC/eClinical t...ical Data Interchange Standards Consortium (CDISC)...) standard. This certification underscores MedNet...
(Date:12/1/2009)..., , CAMBRIDGE, Mass. and TOKYO, Dec. 1 /PRN...l Co., Ltd. announced today the further extension ...rough 2011. This latest extension increases the c...tal committed funding to approximately $90 million...January 2005 with the goal of discovering and deve...
(Date:12/1/2009)..., , CLEARWATER, Fla., Dec. 1 /PRNewswire/ -...rovider of medical supplies, today announced that ...nkruptcy Court for District of Delaware (the "Cour...the marketing and proposed sale of substantially a... November 24, 2009, the Court approved bidding pro...
Breaking Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 1InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 2InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 3Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 1Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 2Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 1Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 2Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 4Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 5
..., Inc. Today,Announced the Top Line Results of the...udy with the Compound Desmoteplase , Aachen (Germa...change, Prime Standard: PA8) and its US partner Fo...d topline results of,the DIAS-2 (Desmoteplase In A...oteplase. The Phase III study was designed to,inve...
...A Plans to Initiate,Phase III Studies in Dry Eye i...-FirstCall/ -- ISTA,Pharmaceuticals, Inc. , today ...alysis of the Company,s Phase IIb clinical study o...atment for dry eye,syndrome. Patients in the ecabe...ctive sign of blink rate. In addition, patients in...
Other Medicine Technology:Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 3ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 5
IMMAGE® Immunochemistry System
Array® 360 Protein, Serology and Drug System
Rheumatoid Factor ADVIA 1650
Rheumatoid Factor II ELISA
Medicine Products: